Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
12.36
-0.09 (-0.72%)
At close: Jul 19, 2024, 4:00 PM
12.35
-0.01 (-0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $745.63 million as of July 22, 2024. Its market cap has decreased by -31.35% in one year.
Market Cap
745.63M
Enterprise Value
316.41M
1-Year Change
-31.35%
Ranking
Category
Stock Price
$12.36
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has increased from $729.40M to $745.63M, an increase of 2.22%. That is a compound annual growth rate of 0.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 745.60M | -31.26% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.50M | 93.73% |
| Dec 31, 2021 | 486.50M | -39.65% |
| Dec 31, 2020 | 806.10M | 10.52% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 766.54M |
| Embecta | 759.52M |
| Phibro Animal Health | 754.99M |
| Evolus | 748.82M |
| Travere Therapeutics | 746.06M |
| 4D Molecular Therapeutics | 744.53M |
| Nuvation Bio | 743.01M |
| Sage Therapeutics | 739.64M |